Children of Mentally Ill Parents-Network - CHIMPS-NET

NCT04369625 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 858

Last updated 2022-11-14

No results posted yet for this study

Summary

In order to identify psychological stress in children and adolescents of mentally ill parents as early as possible, four special intervention programs (CHIMPS-therapy, CHIMPS-Prevention-single, CHIMPS-MFT-group, iCHIMPS) have been developed. These four intervention programs are based on the initial medical situation, indication and need of the families. Thereby, an individually tailored counseling service will be provided. With this current project, the four counseling approaches will be tested at 19 study sites in 12 federal states in Germany. Moreover, the interventions long-term efficacy will be evaluated.

Conditions

  • Mental Health Issue

Interventions

BEHAVIORAL

CHIMPS-T

CHIMPS-T (Children of mentally ill parents) is a family-oriented lowfrequency brief therapy for diagnosis and treatment of mental disorders in children and adolescents.

BEHAVIORAL

CHIMPS-P

CHIMPS-P is a family-oriented prevention for children and adolescents without signs of mental disorders in the initial screening. These families will receive the 3 family sessions from the modular CHIMPS intervention.

BEHAVIORAL

CHIMPS-MFT-group

The CHIMPS-MFT-group is a prevention with a multi-family setting based on the CHIMPS approach. The multi-family intervention comprises 8 sessions for children and adolescents without psychiatric disorders and their families.

BEHAVIORAL

iCHIMPS

iCHIMPS is an online intervention. In terms of content, iCHIMPS is based on the CHIMPS program as well as on other evidence-based interventions of the study group. iCHIMPS will also be comprised of one module for children and adolescents as well as one module for parents; moreover; modules for the family system will be included.

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER
  • Charite University, Berlin, Germany

    collaborator OTHER
  • University Medical Center Rostock

    collaborator OTHER
  • Immanuel Klinik Rüdersdorf

    collaborator UNKNOWN
  • Evangelisches Klinikum Bethel

    collaborator UNKNOWN
  • Universitätsklinikum Köln

    collaborator OTHER
  • University of Göttingen

    collaborator OTHER
  • Ruhr University of Bochum

    collaborator OTHER
  • University Hospital Tuebingen

    collaborator OTHER
  • University Hospital Freiburg

    collaborator OTHER
  • Josefinum Augsburg

    collaborator UNKNOWN
  • University Hospital Augsburg

    collaborator OTHER
  • Klinikum der Universität München

    collaborator UNKNOWN
  • University Hospital, Saarland

    collaborator OTHER
  • University of Magdeburg

    collaborator OTHER
  • Helios Kliniken Schwerin

    collaborator OTHER
  • Universitätsklinikum Marburg

    collaborator UNKNOWN
  • Universitätsklinikum Koblenz - Landau

    collaborator UNKNOWN
  • Pfalzklinikum

    collaborator UNKNOWN
  • HELIOS Hospital, Erfurt, Germany

    collaborator OTHER
  • Bezirkskrankenhaus Günzburg

    collaborator UNKNOWN
  • DAK Gesundheit

    collaborator OTHER
  • Techniker Krankenkasse

    collaborator OTHER
  • BARMER

    collaborator OTHER
  • BKK Mobil Oil

    collaborator INDUSTRY
  • KKH Kaufmännische Krankenkasse

    collaborator UNKNOWN
  • IKK Classic Krankenkasse

    collaborator UNKNOWN
  • AOK Hessen

    collaborator INDUSTRY
  • University of Ulm

    collaborator OTHER
  • University Hospital Heidelberg

    collaborator OTHER
  • aQua-Institut

    collaborator UNKNOWN
  • Leibniz Universität, Center for Health Economics Research Hannover

    collaborator UNKNOWN
  • AFET Bundesverband für Erziehungshilfe e.V.

    collaborator UNKNOWN
  • Dachverband Gemeindepsychiatrie

    collaborator UNKNOWN
  • AOK Baden-Württemberg

    collaborator INDUSTRY
  • LWL Klinik Gütersloh

    collaborator UNKNOWN
  • Staedtisches Klinikum Karlsruhe

    collaborator OTHER
  • Silke Wiegand-Grefe, Prof. Dr.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04369625 on ClinicalTrials.gov